Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 25, 2024

SELL
$4.63 - $15.21 $869,551 - $2.86 Million
-187,808 Reduced 98.0%
3,827 $20,000
Q3 2023

Oct 27, 2023

BUY
$15.21 - $22.88 $2.91 Million - $4.38 Million
191,635 New
191,635 $3.02 Million
Q2 2023

Jul 18, 2023

SELL
$17.74 - $31.87 $904,722 - $1.63 Million
-50,999 Reduced 22.93%
171,431 $3.33 Million
Q1 2023

Apr 13, 2023

BUY
$25.06 - $34.09 $1.8 Million - $2.45 Million
71,802 Added 47.67%
222,430 $6.31 Million
Q4 2022

Jan 23, 2023

BUY
$24.98 - $39.77 $1.56 Million - $2.48 Million
62,456 Added 70.83%
150,628 $0
Q3 2022

Oct 26, 2022

SELL
$26.42 - $47.12 $3.17 Million - $5.65 Million
-119,997 Reduced 57.64%
88,172 $2.33 Million
Q2 2022

Jul 25, 2022

SELL
$41.26 - $51.35 $1.81 Million - $2.25 Million
-43,810 Reduced 17.39%
208,169 $9.25 Million
Q1 2022

May 02, 2022

SELL
$44.58 - $52.6 $1.04 Million - $1.23 Million
-23,326 Reduced 8.47%
251,979 $12.5 Million
Q4 2021

Jan 28, 2022

BUY
$45.82 - $56.9 $12.6 Million - $15.7 Million
275,305 New
275,305 $14 Million

Others Institutions Holding EGRX

About EAGLE PHARMACEUTICALS, INC.


  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $7.81M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.